The impact of alterations in RAD51B, GID4, and POT1 on telomeric content was proportional to tumor purity, but in samples WT for known TMM genes, telomeric content was not impacted by tumor purity (Fig. S3). The gene discussed is RAD51B; the disease is neoplasm.